Intravenously administered digoxin in patients with acute atrial fibrillation: a population pharmacokinetic/pharmacodynamic analysis based on the Digitalis in Acute Atrial Fibrillation trial
Authors:
- for the DAAF Trial GroupFGfor the DAAF Trial Group
- Björn HornestamBHBjörn Hornestam
- 19 February 2003
- journal article
- clinical trial
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 58 (11) , 747-755
Abstract
Atrial fibrillation is commonly treated with intravenously administered digoxin. The main objective of this study was to investigate the relationship between plasma concentration of digoxin and heart rate.Keywords
This publication has 55 references indexed in Scilit:
- Bayesian Parameter Estimation and Population PharmacokineticsClinical Pharmacokinetics, 1992
- Pharmacokinetics of the Digoxin-Quinidine Interaction via Mixed-Effect ModellingClinical Pharmacokinetics, 1992
- Clinical pharmacokinetics: a comprehensive system for therapeutic drug monitoring and prescribing.BMJ, 1984
- Epidemiologic Features of Chronic Atrial FibrillationNew England Journal of Medicine, 1982
- Pharmacokinetics of digoxin: Relationship between response intensity and predicted compartmental drug levels in manJournal of Pharmacokinetics and Biopharmaceutics, 1979
- Estimation of population characteristics of pharmacokinetic parameters from routine clinical dataJournal of Pharmacokinetics and Biopharmaceutics, 1977
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976
- Correlation of Serum Concentrations with Heart Concentrations of Digoxin in Human SubjectsCirculation, 1974
- Relationship of Plasma Digitoxin and Digoxin to Cardiac Response Following Intravenous Digitalization in ManCirculation, 1970
- Electrocardiographic Findings Among the Adult Population of a Total Natural Community, Tecumseh, MichiganCirculation, 1965